Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. (PRTK) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 331 transactions totaling $22.9M, demonstrating a bullish sentiment with $4.4M in net insider flow. The most recent transaction on Sep 21, 2023 involved a transaction of 53,000 shares valued at $0.
PRTK Insider Activity Summary
Who Is Buying PRTK Stock?
No significant insider buying has been recorded for PRTK in the recent period.
Who Is Selling PRTK Stock?
No significant insider selling has been recorded for PRTK in the recent period.
Is Paratek Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PRTK is bullish with an Insider Alignment Score of 60/100 and a net flow of $4.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PRTK Frequently Asked Questions
Understanding PRTK Insider Activity
Insider trading at Paratek Pharmaceuticals, Inc. (PRTK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading PRTK stock, having executed 331 transactions in the past 90 days. The most active insider is Fund Iii, L.p. Omega (Executive), who has made 2 transactions totaling $6.0M.
Related Tools
Track Paratek Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at PRTK file new Form 4 transactions